Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations

Fig. 2

Establishment of EHD1-overexpressing and EHD1-knockdown NSCLC cells. EHD1 was confirmed at both the transcript and protein level in A549 and A549/DDP cell lines (a and b). The NSCLC cell line A549 was transfected with control or EHD1 overexpression (A549-EHD1) vector and analysed for EHD1 expression by immunofluorescence (c-e) and qRT–PCR (i). The CDDP-resistant cell line (A549/DDP) transfected with control or shRNA-EHD1 was analysed for EHD1 expression by immunofluorescence (f-h) and qRT–PCR (j)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us